Insight Partners-backed GraphPad, a provider of data analysis and visualization software for the life sciences industry, completed the acquisition of Biomatters, a provider of Geneious DNA data analysis solutions. Financial terms were not disclosed. "The acquisition of Biomatters is an exciting opportunity to better serve our customers and the scientific community. There is a critical need for scientists and researchers to leverage technology in a way that enhances—not impedes—innovation. As a unified company, we can invest further in these software solutions allowing scientists to stay focused on advancing their research," Thomas Swalla, GraphPad CEO.